Kyle W. Gano

2017

In 2017, Kyle W. Gano earned a total compensation of $2.4M as Chief Business Development Officer at Neurocrine Biosciences, a 4% increase compared to previous year.

Compensation breakdown

Bonus$215,625
Option Awards$1,426,200
Salary$375,000
Stock Awards$328,624
Other$5,123
Total$2,350,572

Gano received $1.4M in option awards, accounting for 61% of the total pay in 2017.

Gano also received $215.6K in bonus, $375K in salary, $328.6K in stock awards and $5.1K in other compensation.

Rankings

In 2017, Kyle W. Gano's compensation ranked 4,731st out of 14,666 executives tracked by ExecPay. In other words, Gano earned more than 67.7% of executives.

ClassificationRankingPercentile
All
4,731
out of 14,666
68th
Division
Manufacturing
1,674
out of 5,770
71st
Major group
Chemicals And Allied Products
490
out of 2,074
76th
Industry group
Drugs
376
out of 1,730
78th
Industry
Biological Products, Except Diagnostic Substances
70
out of 316
78th
Source: SEC filing on April 17, 2019.

Gano's colleagues

We found four more compensation records of executives who worked with Kyle W. Gano at Neurocrine Biosciences in 2017.

2017

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2017

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

2017

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2017

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

News

In-depth

You may also like